This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: University of California. Active years: 2016.
Company Filing History:
Years Active: 2016
Title: Saori Furuta: Innovator in Cancer Treatment
Introduction
Saori Furuta is a prominent inventor based in Emeryville, CA (US). She has made significant contributions to the field of cancer research, particularly in the detection and treatment of breast cancer. Her innovative work focuses on overcoming resistance to EGFR inhibitors, which are commonly used in cancer therapies.
Latest Patents
Saori Furuta holds a patent for her groundbreaking work titled "Detecting and treating breast cancer resistance to EGFR inhibitors." This patent describes therapeutic compositions and methods for treating cancer. Specifically, it provides methods related to the inhibition of FAM83A (family with sequence similarity 83). The application also outlines methods for diagnosing cancer resistance to EGFR inhibitors, including a method for detecting increased FAM83A levels.
Career Highlights
Furuta is affiliated with the University of California, where she continues her research and development in cancer therapies. Her work has the potential to significantly impact the treatment options available for patients facing breast cancer.
Collaborations
Some of her notable coworkers include Roland Meier and Sun-Young Moonlee, who contribute to her research efforts and collaborative projects.
Conclusion
Saori Furuta's innovative work in cancer treatment exemplifies the importance of research in overcoming medical challenges. Her contributions are paving the way for more effective therapies for breast cancer patients.